Skip to main content
. 2014 Dec 2;112(1):207–216. doi: 10.1038/bjc.2014.596

Table 7. National campaign: first definitive treatment received for lung cancer for the campaign and control periods.

  Control period
Campaign period
First definitive treatmenta No. of cases (% of all cases)
    No. of cases (% of all cases)
   
  FebruaryApril 2011 FebruaryApril 2012 Change in proportion P-value May–July 2011 May–July 2012 Change in proportion P-value
Surgery 1076 (14.5%) 1145 (15.0%) +0.5 0.425 1043 (13.7%) 1331 (16.0%) +2.3 <0.001
Chemotherapy 1909 (25.8%) 1930 (25.3%) −0.5 0.475 1875 (24.5%) 2150 (25.8%) +1.2 0.069
Radiotherapy 1366 (18.4%) 1354 (17.7%) −0.7 0.253 1410 (18.5%) 1462 (17.5%) −0.9 0.132
Palliative care/active monitoring 2469 (33.3%) 2709 (35.5%) +2.2 0.006 2661 (34.8%) 2817 (33.8%) −1.0 0.168
Any treatmentb 6752 (91.2%) 7014 (91.9%) +0.7 0.146 6890 (90.2%) 7675 (92.1%) +1.9 <0.001
No treatmentc 652 (8.8%) 622 (8.1%) −0.7 0.146 749 (9.8%) 660 (7.9%) −1.9 <0.001
Total 7404 (100%) 7636 (100%) 7639 (100%) 8335 (100%)

Results in bold indicate a statistically significant change between 2011 and 2012 (two-sample test of proportions; P<0.05).

a

Patients are counted more than once if they have multiple treatment types on the same earliest treatment date.

b

Number of patients receiving any treatment (surgery, chemotherapy, radiotherapy, palliative care, or active monitoring).

c

Patients with no treatment type recorded in the database. However, some patients may have had treatment that has not been recorded.